Table 1 Clinicopathological characteristics for 516 bladder cancer patients.
Characteristics | |
|---|---|
Age, median (IQR) | 66 (57–73) |
Gender | |
female | 80 (15.5%) |
male | 436 (84.5%) |
Smoking history | |
no | 355 (68.8%) |
yes | 161 (31.2%) |
Alcohol-drinking history | |
no | 449 (87.0%) |
yes | 67 (13%) |
Hypertension | |
no | 367 (71.1%) |
yes | 149 (28.9%) |
Histology subtype | |
transitional cell carcinoma | 488 (94.6%) |
non-transitional cell carcinoma | 28 (5.4%) |
Grade | |
2 | 126 (24.4%) |
3 | 385 (75.6%) |
T-stage | |
NMIBC | 162 (31.4%) |
MIBC | 354 (68.6%) |
N-stage | |
negative | 81 (15.7%) |
positive | 435 (84.3%) |
M-stage | |
negative | 511 (99.03%) |
positive | 5 (0.97%) |
Adjunctive chemotherapy | |
yes | 91 (17.6%) |
no | 425 (82.4%) |
ASA grade | |
1&2 | 436 (84.5%) |
3&4 | 80 (15.5%) |
Anemia | |
present | 144 (27.9%) |
absent | 342 (72.1%) |
Hypoalbuminemia | |
present | 43 (8.3%) |
absent | 442 (85.7%) |
PLR, median (IQR) | 133.8 (98.22–180.23) |
HALP, median (IQR) | 41.2 (27.78–58.71) |
